Abbott Laboratories

ABT
106,49
0,20 (0,19%)
Pre Mercato
Ultimo aggiornamento: 12:23:26
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/4/202415:00PRNUSAbbott's Breakthrough Dissolving Stent Receives FDA Approval..
17/4/202417:37IHMARKETNEWSAbbott Laboratories Reports Strong Q1 Sales Growth Amid..
17/4/202413:30PRNUSAbbott Reports First-Quarter 2024 Results and Raises..
17/4/202412:59IHMARKETNEWSUS Index Futures See Gains, Oil Prices Dip
03/4/202413:12IHMARKETNEWSCal-Maine Surges on Strong Quarterly Performance, Taiwan..
02/4/202415:00PRNUSAbbott Receives FDA Approval for TriClip™, First-of-Its-Kind..
01/4/202415:00PRNUSAbbott Receives FDA Clearance for Whole Blood Rapid Test to..
27/3/202421:30PRNUSAbbott Hosts Conference Call for First-Quarter Earnings
19/3/202413:00PRNCAUne première au Canada -- Abbott fait progresser le..
06/3/202415:00PRNUSReal-World Data Show Abbott's FreeStyle Libre® Systems and..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:53EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:45EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:39EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:32EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:22EDGAR2Form 144 - Report of proposed sale of securities
28/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:02EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202416:19PRNUSAbbott Declares 401st Consecutive Quarterly Dividend
14/2/202400:47PRNUSFDA Advisory Committee Votes in Favor of Abbott's..
13/2/202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202411:31IHMARKETNEWSSantander’s Stock Declines Amid Sanctions Evasion Scandal,..
01/2/202415:00PRNUSNew Study Shows Mixed Reality Technology for Blood Donation..
31/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:00PRNUSAbbott Launches New PROTALITY™ Brand to Support Adults on..
29/1/202422:10EDGAR2Form 8-K - Current report
29/1/202422:04EDGAR2Form 144 - Report of proposed sale of securities
26/1/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202415:00PRNUSAbbott Launches World's Smallest Rechargeable System With..
Apertura: Min: Max:
Chiusura: 106,29

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network